| Literature DB >> 31997543 |
Yuya Watanabe1,2,3,4, Yosuke Yamada2,4, Tsukasa Yoshida2,4,5, Keiichi Yokoyama6,7, Motoko Miyake3, Emi Yamagata8, Minoru Yamada9, Yasuko Yoshinaka6,7, Misaka Kimura2,3.
Abstract
BACKGROUND: In longevity societies, one of the most serious social issues is sarcopenia and/or frailty. Preventing them is important for maintaining independence and quality of life in the older population. This study investigated the effect of a self-monitoring comprehensive geriatric intervention programme (CGIP) on physical function and muscle size in community-dwelling older adults. We compared the effects of a CGIP using weekly class-styled (CS) sessions and a home-based (HB) programme.Entities:
Keywords: Behavioural change programme; Low-load resistance exercise; Physical function; Self-monitoring intervention
Mesh:
Year: 2020 PMID: 31997543 PMCID: PMC7015250 DOI: 10.1002/jcsm.12504
Source DB: PubMed Journal: J Cachexia Sarcopenia Muscle ISSN: 2190-5991 Impact factor: 12.910
Figure 1Intervention and non‐intervention regions in Kameoka City. CS, class‐styled; HB, home‐based.
Figure 2A flow chart of the cluster‐RCT. CS, class‐styled; HB, home‐based; LTC, long‐term care; RCT, randomized controlled trial. Cluster‐RCT #1: Long‐term comparison between 10 intervention regions and 11 non‐intervention regions (LTC certification, medical cost, and mortality); cluster‐RCT #2: short‐term comparison between the CS (five regions) and HB (five regions) groups (daily physical activities, physical functions, and skeletal muscle size). This research paper reported the results of the cluster‐RCT #2.
Baseline characteristics of health‐related variables
| CS ( | HB ( |
| |||
|---|---|---|---|---|---|
| Variables |
|
| |||
| Education attainment (y) | 227 | 12.3 ± 2.6 | 250 | 12.2 ± 2.6 | 0.754 |
| Lives alone (%) | 239 | 25 (10.5) | 261 | 27 (10.3) | 0.632 |
| Poor subjective economy status (%) | 238 | 153 (64.3) | 267 | 167 (62.5) | 0.712 |
| Good self‐reported health (%) | 239 | 210 (87.9) | 265 | 233 (87.9) | 1.000 |
| Current drinker (%) | 245 | 103 (42.0) | 269 | 100 (37.2) | 0.279 |
| Current smoker (%) | 244 | 15 (6.1) | 264 | 16 (6.1) | 1.000 |
| Arthralgia (%) | 244 | 93 (38.1) | 269 | 104 (38.7) | 0.899 |
| Good sleep quality (%) | 248 | 189 (76.2) | 270 | 196 (72.6) | 0.346 |
| Taking medication (%) | 240 | 203 (84.6) | 256 | 197 (77.0) | 0.032 |
| Self‐reported diseases being treated or have sequelae (medical history) | 251 | 275 | |||
| None (%) | 16 (6.4) | 38 (13.8) | 0.006 | ||
| Hypertension (%) | 93 (37.1) | 96 (34.9) | 0.649 | ||
| Stroke‐related disease (%) | 8 (3.2) | 7 (2.5) | 0.795 | ||
| Cardiovascular diseases (%) | 26 (10.4) | 37 (13.5) | 0.286 | ||
| Diabetes (%) | 33 (13.1) | 16 (5.8) | 0.004 | ||
| Dyslipidaemia (%) | 38 (15.1) | 26 (9.5) | 0.061 | ||
| Pneumonia, bronchitis (%) | 10 (4.0) | 11 (4.0) | 1.000 | ||
| Gastrointestinal, liver, or gallbladder diseases (%) | 25 (10.0) | 26 (9.5) | 0.883 | ||
| Kidney or prostate diseases (%) | 13 (5.2) | 20 (7.3) | 0.323 | ||
| Osteoporosis, arthropathy (%) | 51 (20.3) | 33 (12.0) | 0.012 | ||
| Fall, fracture (%) | 9 (3.6) | 6 (2.2) | 0.434 | ||
| Cancer (%) | 10 (4.0) | 7 (2.5) | 0.461 | ||
| Blood or immune diseases (%) | 4 (1.6) | 3 (1.1) | 0.615 | ||
| Depression (%) | 3 (1.2) | 3 (1.1) | 1.000 | ||
| Dementia (%) | 3 (1.2) | 2 (0.7) | 0.673 | ||
| Parkinson's disease (%) | 0 (0.0) | 0 (0.0) | — | ||
| Eye‐related diseases (%) | 36 (14.3) | 50 (18.2) | 0.234 | ||
| Ear‐related diseases (%) | 16 (6.4) | 15 (5.5) | 0.655 | ||
| Other diseases (%) | 25 (10.0) | 35 (12.7) | 0.319 | ||
Education attainment is expressed as means ± standard deviation and using t‐test for statistics. Depression and dementia are expressed as number (rate) and using Fisher's exact test for statistics. Others are expressed as number (rate) and using χ2 test for statistics. CS, class‐styled; HB, home‐based.
Baseline characteristics and adherence in both intervention groups
| Variables | CS ( | HB ( |
|
|---|---|---|---|
| Age (y) | 74.0 ± 5.4 | 74.0 ± 5.6 | 0.876 |
| Number of women, | 139 (57.2%) | 161 (58.8%) | 0.720 |
| Height (cm) | 156.4 ± 8.7 | 156.6 ± 8.4 | 0.803 |
| Weight (kg) | 55.8 ± 10.0 | 56.1 ± 9.7 | 0.752 |
| Body mass index (kg/m2) | 22.8 ± 3.3 | 22.8 ± 3.0 | 0.874 |
| Participation in both initial lectures (%) | 100 (100–100) | 100 (100–100) | 0.146 |
| Participation in post‐intervention physical measurement, | 205 (84.4%) | 204 (74.5%) | 0.004 |
| Daily log return (%) | 100 (67–100) | 100 (50–100) | 0.994 |
Characteristics of the participants are expressed as means ± standard deviation. Participation in both initial lectures and daily log return are reported as median and interquartile ranges. CS, class‐styled; HB, home‐based.
Primary and secondary outcomes before and after the intervention in both groups
| CS ( | HB ( |
Time effect
|
Interaction
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Before | After | Change |
| Before | After | Change | |||
| Primary outcomes | ||||||||||
| Grip strength (kg) | 243 | 26.4 ± 7.8 | 26.6 ± 7.7 | 1.5 (0.03) | 273 | 26.9 ± 7.7 | 27.1 ± 7.9 | 1.1 (0.03) | 0.017 (5.8) | 0.768 (0.1) |
| Knee extension strength (kg) | 239 | 27.8 ± 10.9 | 31.3 ± 10.9 | 18.5 | 264 | 29.7 ± 10.9 | 31.9 ± 11.2 | 10.6 (0.20) | <0.001 (110.4) | 0.017 (5.7) |
| Normal walking speed (m/s) | 241 | 1.35 ± 0.25† | 1.39 ± 0.26 | 3.7 (0.15) | 270 | 1.40 ± 0.25 | 1.43 ± 0.26 | 2.8 (0.12) | <0.001 (16.9) | 0.629 (0.02) |
| Maximum walking speed (m/s) | 238 | 1.81 ± 0.32 | 1.89 ± 0.34 | 4.7 | 269 | 1.84 ± 0.34 | 1.86 ± 0.34 | 1.8 (0.06) | <0.001 (32.8) | 0.001 (11.1) |
| Timed up‐and‐go test (s) | 237 | 7.59 ± 2.17 | 7.17 ± 2.16 | −4.7 | 266 | 7.07 ± 1.78 | 7.00 ± 1.93 | −0.2 (0.04) | <0.001 (23.0) | <0.001 (12.4) |
| Five‐time chair standing (s) | 235 | 8.36 ± 2.67 | 7.34 ± 2.55 | −9.7 (0.39) | 263 | 8.29 ± 2.58 | 7.48 ± 2.14 | −7.3 (0.34) | <0.001 (85.0) | 0.286 (1.1) |
| Chair standing for 30 s (numbers) | 230 | 20.1 ± 5.6 | 22.6 ± 6.3 | 15.5 (0.42) | 256 | 20.2 ± 5.6 | 22.4 ± 6.4 | 12.8 (0.36) | <0.001 (110.4) | 0.479 (0.5) |
| Functional reach (cm) | 241 | 35.5 ± 8.0 | 36.7 ± 7.4 | 6.1 (0.16) | 270 | 36.1 ± 7.6 | 37.2 ± 7.3 | 5.3 (0.15) | <0.001 (15.5) | 0.876 (0.02) |
| Chair stepping (numbers) | 242 | 26.3 ± 6.1 | 29.0 ± 6.6 | 11.8 (0.43) | 269 | 26.3 ± 5.8 | 28.7 ± 5.7 | 11.6 (0.41) | <0.001 (179.1) | 0.412 (0.7) |
| Vertical jump index (m × kg) | 218 | 12.1 ± 5.1 | 12.6 ± 5.2 | 7.2 (0.10) | 254 | 12.3 ± 5.3 | 12.8 ± 5.6 | 5.0 (0.09) | <0.001 (25.1) | 0.855 (0.03) |
| Anterior thigh MT (mm) | 242 | 41.6 ± 6.5 | 42.7 ± 6.3 | 3.2 (0.18) | 271 | 42.7 ± 6.6 | 44.0 ± 6.5 | 3.5 (0.20) | <0.001 (66.8) | 0.526 (0.4) |
| Secondary outcomes | ||||||||||
| Daily number of step (numbers) | 233 | 5006 ± 2782 | 6324 ± 3496 | 1318 | 253 | 4903 ± 2890 | 5595 ± 3447 | 692 (0.22) | <0.001 (80.0) | 0.006 (7.8) |
| MVPA (METs × hour/week) | 233 | 18.1 ± 14.9 | 23.8 ± 17.5 | 5.8 (0.36) | 253 | 17.7 ± 13.7 | 21.2 ± 18.0 | 3.5 (0.22) | <0.001 (58.2) | 0.062 (3.5) |
Data are expressed as means ± standard deviation. The changes in primary outcomes are expressed as percentages, while the changes in secondary outcomes are expressed as increments. The F values are shown in parentheses in P‐value column. The effect size was shown in parentheses in change column. CS, class‐styled; HB, home‐based; METs, metabolic equivalents; MT, muscle thickness; MVPA, moderate‐to‐vigorous physical activity.
<0.05 vs. before intervention.
<0.01 vs. before intervention.
<0.001 vs. before intervention.
<0.05 CS vs. HB.
<0.01 CS vs. HB.
<0.001 CS vs. HB.